Loading chart…
CLOSED
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations for human and animal healthcare in India and internationally. It offers injectable critical care solutions, anti-infectives, antifungals, anti-ulcer therapies, oncology support, cardiovascular therapies, and women's healthcare solutions such as gonadotropins, hormonal therapies, and haematinic formulations. The company also develops pharmaceutical and nutritional solutions for livestock, poultry, equine, and companion animals.
Lyka Labs Limited (LYKALABS) is listed on the NSE in the Healthcare sector, Biotechnology industry. The LYKALABS share price is ₹72.68 (-2.18% today), with a market capitalisation of ₹3B. MarketRipple tracks the LYKALABS investment thesis, the ripple-chain impact of market events on Lyka Labs Limited, and the Healthcare sector outlook.
Open
₹74.90
High
₹74.90
Low
₹72.05
Prev. Close
₹74.30
52W High
₹100.94
52W Low
₹44.10
Day range
₹72.05–₹74.90
52-week range
₹44.10–₹100.94
Volume
11K
P/E
—
ROE
-10.9%
D/E
0.53
Margin
-6.6%
Lyka Labs Limited (NSE: LYKALABS) is currently trading at ₹72.68 (-2.18%).
Lyka Labs Limited's market capitalization is ₹3B.
Lyka Labs Limited operates in the Healthcare sector (Biotechnology).